November 28, 2025

Definitive Healthcare Corp. (DH) Stock Analysis: Uncovering a 44% Potential Upside Amidst Challenging Metrics

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the Health Information Services sector, offers investors a compelling yet complex narrative. Based in Framingham, Massachusetts, the company leverages a software-as-a-service..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Healthcare Innovator with Strategic Partnerships and Revenue Growth

Fortrea Holdings Inc. (NASDAQ: FTRE), a burgeoning player in the healthcare sector, operates within the biotechnology industry and has carved out a niche by offering comprehensive biopharmaceutical and medical device..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 96% Potential Upside and Analyst Confidence

Bioventus Inc. (NASDAQ: BVS), a North Carolina-based medical device company, is turning heads in the healthcare sector with a compelling potential upside of 96.08%, according to recent analyst ratings. Specializing..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Exploring a 35% Potential Upside in the Biotech Sector

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a biotechnology firm based in Cambridge, Massachusetts, stands out in the healthcare sector with its innovative approach to treating neurodegenerative diseases. With a market capitalization..

Talkspace, Inc. (TALK) Stock Analysis: A 49% Upside Opportunity in Virtual Behavioral Healthcare

Talkspace, Inc. (NASDAQ: TALK) is making waves in the healthcare sector with its innovative approach to mental health services. As a virtual behavioral healthcare company, Talkspace connects patients with licensed..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating the Diagnostics Sector with a 10% Upside Potential

For investors eyeing the healthcare sector, Myriad Genetics, Inc. (NASDAQ: MYGN) stands out as a key player in the field of molecular diagnostics and precision medicine. With a market capitalization..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Uncovering a 26% Upside Potential Amidst Clinical Advances

Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its ambitious cancer therapy pipeline and a promising upside potential of 26.07%. Based..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 73% Potential Upside for Investors

Tilray Brands, Inc. (NASDAQ: TLRY) stands as a prominent player in the healthcare sector, particularly in the niche of specialty and generic drug manufacturing. As a lifestyle consumer products company,..

Mind Medicine (MNMD) Stock Analysis: Assessing a 111.87% Potential Upside in the Biotech Space

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a trailblazer in the biopharmaceutical sector, is making waves among investors with its innovative approach to treating brain health disorders. With a market capitalization..

AMN Healthcare Services Inc (AMN) Stock Analysis: Evaluating a 20% Upside Potential in a Challenging Market

AMN Healthcare Services Inc (NYSE: AMN) is a notable player in the healthcare sector, particularly within the medical care facilities industry. Based in Dallas, Texas, AMN specializes in providing technology-enabled..

Precigen, Inc. (PGEN) Stock Analysis: A Biotech with 127% Potential Upside

Precigen, Inc. (NASDAQ: PGEN) is capturing investor attention with its impressive potential upside of 127.27%, as suggested by current analyst ratings. As a forward-thinking player in the biotechnology sector, Precigen..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges in the Medical Device Sector

Surmodics, Inc. (NASDAQ: SRDX), a key player in the medical devices sector, is currently navigating a complex landscape characterized by challenging financial metrics and a mixed outlook from analysts. With..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 33.6% Upside Potential with Promising Analyst Ratings

Theravance Biopharma, Inc. (NASDAQ: TBPH), a prominent player in the biotechnology sector, is capturing the attention of investors with its compelling growth potential and strategic developments. Based in South San..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with a Unique Growth Story

Sonida Senior Living, Inc. (NASDAQ: SNDA), a prominent player in the healthcare sector specializing in medical care facilities, commands attention from investors seeking exposure to the senior housing market in..

GH Research PLC (GHRS) Stock Analysis: Biotech Firm with Over 100% Potential Upside Attracts Strong Buy Ratings

GH Research PLC (NASDAQ: GHRS) stands out in the healthcare sector as a promising player in the biotechnology industry. Based in Dublin, Ireland, this clinical-stage biopharmaceutical company is gaining attention..

Keros Therapeutics, Inc. (KROS) Stock Analysis: A Biotech Gem with a 32.86% Potential Upside

Keros Therapeutics, Inc. (NASDAQ: KROS) stands out in the healthcare sector, particularly within the biotechnology industry, as a promising player with significant growth potential. Focused on developing novel therapeutics for..

Weave Communications, Inc. (WEAV) Stock Analysis: Unpacking a 63.53% Potential Upside

Weave Communications, Inc. (NASDAQ: WEAV) has been a notable player within the healthcare sector, specializing in health information services. As of its latest market data, the company boasts a market..

Castle Biosciences, Inc. (CSTL): Analyzing Growth Potential Amidst a Challenging Valuation Landscape

Castle Biosciences, Inc. (NASDAQ: CSTL), a prominent player in the molecular diagnostics sector, has captured investor attention with its cutting-edge diagnostic solutions. Specializing in test solutions for dermatologic cancers, Barrett’s..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a 113% Potential Upside in the Biotech Arena

Sana Biotechnology, Inc. (NASDAQ: SANA), a rising star in the biotech sector, is capturing the attention of investors with its ambitious approach to engineered cell medicines. As the company delves..

uniQure N.V. (QURE) Stock Analysis: Assessing the 111% Potential Upside in Biotechnology

Investors with an eye on groundbreaking biotechnological advancements might find uniQure N.V. (NASDAQ: QURE) a compelling opportunity. As a key player in the healthcare sector, uniQure focuses on developing gene..

Search

Funds

November 28, 2025

Search

Funds

November 28, 2025

FTSE 100

Funds